Research

rs1049434 — SLC16A1 A1470T

Primary lactate transporter in skeletal muscle — affects lactate clearance during high-intensity exercise and recovery between intervals

Moderate Benign

Details

Gene
SLC16A1
Chromosome
1
Risk allele
A
Protein change
p.Asp490Glu
Consequence
Missense
Inheritance
Codominant
Clinical
Benign
Evidence
Moderate
Chip coverage
v3 v4 v5

Population Frequency

TT
33%
AT
49%
AA
18%

Ancestry Frequencies

latino
47%
south_asian
45%
european
44%
east_asian
34%
african
13%

Related SNPs

Category

Fitness & Body

MCT1 A1470T — Your Lactate Clearance Blueprint

Every time you push past your comfort zone during exercise — sprinting, lifting heavy, climbing a steep hill — your muscles ramp up anaerobic glycolysis11 anaerobic glycolysis
The metabolic pathway that breaks down glucose without oxygen, producing lactate and ATP rapidly during intense effort
and flood the local environment with lactate22 lactate
Often called "lactic acid" in popular culture, though at physiological pH it exists almost entirely as the lactate anion. Far from being a waste product, lactate is a crucial fuel source for the heart, brain, and oxidative muscle fibers
. Getting that lactate out of the producing muscle and into tissues that can burn it as fuel is the job of monocarboxylate transporter 1 (MCT1), encoded by the SLC16A1 gene on chromosome 1.

The A1470T variant (rs1049434) changes a single amino acid at position 490 of the MCT1 protein — aspartate to glutamate33 aspartate to glutamate
Both are negatively charged amino acids, so this is a conservative substitution. However, the subtle structural difference is enough to alter transport kinetics measurably
(p.Asp490Glu). This seemingly minor change has measurable effects on how efficiently your muscles shuttle lactate across cell membranes during high-intensity exercise.

The Mechanism

MCT1 sits in the sarcolemma44 sarcolemma
The cell membrane of skeletal muscle fibers
of skeletal muscle fibers, particularly in oxidative (type I) and intermediate (type IIa) fibers. It works as a symporter, moving one lactate molecule together with one proton (H+) across the membrane. This is essential for the "lactate shuttle"55 "lactate shuttle"
A concept introduced by George Brooks: lactate produced by glycolytic fibers is transported via MCT1 into oxidative fibers and other tissues (heart, brain, liver) where it is used as fuel or converted back to glucose
— the process by which lactate produced during intense effort is redistributed to tissues that oxidize it for energy.

The A allele at rs1049434 produces a transporter with higher Vmax66 Vmax
Maximum velocity of the transport reaction — the rate of lactate movement when the transporter is fully saturated
for lactate transport. The original functional characterization77 functional characterization
Merezhinskaya N et al. Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport. Muscle Nerve, 2000
found that individuals homozygous for the A allele had lactate transport rates 60-65% higher than T allele carriers. The T allele produces a transporter with increased Km88 Km
Michaelis constant — the substrate concentration at which the enzyme operates at half its maximum rate. A higher Km means lower affinity, requiring more substrate to achieve the same transport rate
, meaning lower affinity for lactate and reduced transport capacity under physiological conditions.

The Evidence

The association between rs1049434 and exercise performance has been replicated across multiple independent cohorts and sport types:

A large multi-ethnic study99 large multi-ethnic study
Guilherme JPL et al. The MCT1 gene Glu490Asp polymorphism (rs1049434) is associated with endurance athlete status, lower blood lactate accumulation and higher maximum oxygen uptake. Biol Sport, 2021
of 2,075 subjects (1,208 Brazilian, 867 European) found the T allele significantly overrepresented among endurance athletes compared to controls. In a subset of 66 Hungarian athletes, TT carriers accumulated less blood lactate after high-intensity effort, and 46 Russian athletes with the TT genotype had higher VO2max.

Fedotovskaya et al.1010 Fedotovskaya et al.
Fedotovskaya ON et al. A common polymorphism of the MCT1 gene and athletic performance. Int J Sports Physiol Perform, 2014
studied 323 Russian athletes and 467 controls, finding the A allele at 71.8% in endurance athletes versus 62.5% in controls (P < 0.0001). Among 79 rowers, T allele carriers had elevated post-exercise blood lactate concentrations.

In a repeated sprint study1111 repeated sprint study
Massidda M et al. Influence of the MCT1-T1470A polymorphism (rs1049434) on repeated sprint ability and blood lactate accumulation in elite football players. Eur J Appl Physiol, 2021
of 26 elite Italian football players, A allele carriers completed the 5th and 6th sprints in a 6 x 30m test approximately 0.37-0.40 seconds faster than TT carriers — a meaningful difference at the elite level.

A separate injury study1212 injury study
Massidda M et al. Influence of the MCT1 rs1049434 on Indirect Muscle Disorders/Injuries in Elite Football Players. Sports Med Open, 2015
of 173 elite Italian football players over five seasons found that AA carriers had significantly higher muscle injury rates (1.57 per season) compared to TT carriers (0.09 per season, P = 0.04), suggesting the higher lactate transport activity may contribute to greater metabolic stress on muscle fibers.

Practical Implications

This variant influences how you should structure high-intensity training. If you carry two copies of the A allele (AA), your MCT1 transporter works at peak capacity — you clear lactate efficiently between sprints and can maintain power output across repeated efforts. However, this efficiency comes with a trade-off: higher lactate flux through the muscle membrane may increase metabolic stress and injury susceptibility.

If you carry two copies of the T allele (TT), your lactate clearance is reduced, meaning you may need longer recovery between high-intensity intervals. However, your muscles may compensate by developing greater oxidative capacity and fat oxidation, which could benefit longer-duration endurance events.

The heterozygous AT genotype, carried by roughly half the population, represents an intermediate transporter capacity that balances sprint recovery with metabolic resilience.

Interactions

MCT1 works in concert with other monocarboxylate transporters. MCT4 (SLC16A3) handles lactate export from glycolytic fast-twitch fibers, while MCT1 handles import into oxidative fibers. Variants in both genes may interact to determine overall lactate kinetics during exercise.

The ACTN3 R577X variant (rs1815739) also influences muscle fiber type composition and exercise phenotype. Individuals with both the MCT1 AA genotype and ACTN3 RR genotype may have a compounded advantage for repeated sprint and power activities, though this specific interaction has not been studied in controlled trials.

Genotype Interpretations

What each possible genotype means for this variant:

AT “Intermediate Transport” Intermediate Caution

Moderate MCT1 activity — balanced lactate clearance profile

The AT heterozygous genotype produces a mix of MCT1 protein variants with intermediate transport kinetics. In the Guilherme et al. 2021 multi-ethnic study, AT carriers showed intermediate blood lactate levels between AA and TT homozygotes after intense exercise.

This genotype is the most common across all studied populations. In the football studies, AT carriers performed between the AA and TT groups in both repeated sprint tests and injury rates. The intermediate transporter activity provides a versatile metabolic profile suitable for diverse training modalities.

TT “Low Lactate Transport” Reduced Caution

Reduced MCT1 activity — longer recovery needed, endurance advantage

The TT genotype produces MCT1 with the lowest Vmax for lactate transport. In functional studies, TT carriers had lactate transport rates 60-65% lower than AA carriers. This means lactate produced during high-intensity glycolytic activity is cleared more slowly from the extracellular space.

Paradoxically, despite lower transport capacity, TT carriers in the Guilherme et al. 2021 study showed lower blood lactate accumulation after intense exercise and higher VO2max. The explanation likely involves compensatory adaptations: with less efficient lactate export via MCT1, muscle fibers may upregulate oxidative metabolism, burn lactate locally rather than exporting it, and develop greater mitochondrial density. This creates an endurance advantage.

In the repeated sprint study, TT carriers were 0.37-0.40 seconds slower on the 5th-6th sprints compared to A allele carriers, reflecting their slower lactate clearance during repeated maximum efforts. However, TT carriers had the lowest muscle injury rates (0.09 per season vs 1.57 for AA).

AA “High Lactate Transport” High Caution

Maximum MCT1 transporter activity — optimized for repeated sprint recovery

The AA genotype produces MCT1 protein with the highest Vmax for lactate transport across the sarcolemma. In Merezhinskaya et al.'s original functional study, AA carriers had erythrocyte lactate transport rates 60-65% higher than T allele carriers.

In the Massidda et al. 2021 repeated sprint study of elite football players, A allele carriers completed the 5th and 6th sprints in a 6 x 30m protocol approximately 0.37-0.40 seconds faster than TT carriers. This reflects superior ability to clear lactate between efforts and maintain power output.

However, the AA genotype was also associated with significantly higher muscle injury rates in a five-season study of 173 elite football players (1.57 injuries per season for AA vs 0.09 for TT). The mechanism may involve greater metabolic stress on muscle fibers from higher lactate flux, or it may reflect the higher training intensities that AA carriers can sustain.

Key References

PMID: 10590411

Merezhinskaya et al. 2000 — first identification of rs1049434 in patients with reduced erythrocyte lactate transport, establishing the functional significance of the Asp490Glu change

PMID: 34475628

Guilherme et al. 2021 — multi-ethnic study (2,075 subjects) showing T allele overrepresented in endurance athletes, associated with lower blood lactate and higher VO2max

PMID: 23628675

Fedotovskaya et al. 2014 — A allele and AA genotype enriched in Russian endurance athletes (A allele 71.8% vs 62.5% in controls), T carriers had higher blood lactate after rowing

PMID: 34480633

Massidda et al. 2021 — A allele carriers completed 5th-6th sprints 0.37-0.40s faster than TT carriers in elite football repeated sprint test

PMID: 26478856

Massidda et al. 2015 — AA genotype associated with significantly higher muscle injury incidence (1.57 vs 0.09 per season) in 173 elite Italian football players

PMID: 29985759

Onali et al. 2018 — world population survey of 2,504 genotypes showing T allele at 86-91% in Sub-Saharan Africans vs 49-69% in other regions

PMID: 34678924

Benitez-Flores et al. 2021 — review proposing MCT1 genotype for individualizing high-intensity training prescription based on lactate handling capacity